Challenging exchange rate makes Novozymes downgrade guidance

Danish enzyme producer Novozymes exits this year's second quarter slightly weaker than expected and is now downgrading its full-year guidance in DKK. Meanwhile, Bioenergy shows growth.

Photo: Novozymes/ PR

Novozymes emerged from this year's second quarter slightly weaker than expected by analysts, and the company is now downgrading its forecast for sales growth in Danish currency from 3-6 percent to 1-4 percent.

CEO Peder Holk Nielsen explains in the interim report that the downgrade is solely due to challenging exchange rate markets.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Siemens Gamesa's deep financial woes are halfway self-inflicted

Despite successfully forwarding the external costs to customers, onshore wind projects valued at EUR 2bn are being delivered at zero-profit margins in the years to come, according to the turbine maker’s CEO. Here and there, things might have moved a bit too fast.

Siemens Gamesa drags down majority shareholder

Despite better sales than expected in the gas business, Siemens Energy downgrades its full-year guidance in the wake of Siemens Gamesa’s announcement of potentially massive losses in 2022.

Further reading

Related articles

Latest News

See all jobs